ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 128 filers reported holding ANAPTYSBIO INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,074,000 | -47.7% | 39,600 | -50.0% | 0.00% | 0.0% |
Q2 2021 | $2,054,000 | +0.2% | 79,200 | -16.9% | 0.00% | -50.0% |
Q4 2020 | $2,050,000 | +20.0% | 95,354 | -17.7% | 0.01% | 0.0% |
Q3 2020 | $1,708,000 | -67.0% | 115,800 | -50.1% | 0.01% | -40.0% |
Q2 2020 | $5,182,000 | +238.7% | 231,944 | +114.1% | 0.01% | +150.0% |
Q1 2020 | $1,530,000 | -68.0% | 108,344 | -20.6% | 0.00% | -60.0% |
Q3 2019 | $4,774,000 | -38.7% | 136,420 | -1.2% | 0.01% | -33.3% |
Q2 2019 | $7,792,000 | +19.3% | 138,096 | +54.4% | 0.02% | -42.3% |
Q1 2019 | $6,532,000 | +29.0% | 89,412 | +12.6% | 0.03% | +18.2% |
Q4 2018 | $5,065,000 | -27.0% | 79,408 | +14.1% | 0.02% | -12.0% |
Q3 2018 | $6,942,000 | +381.1% | 69,583 | +242.5% | 0.02% | +316.7% |
Q2 2018 | $1,443,000 | -30.9% | 20,315 | +1.3% | 0.01% | -25.0% |
Q1 2018 | $2,088,000 | – | 20,057 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |